In contrast, three of 12 (25%) osteosarcoma samples, two of which were osteoblastic osteosarcoma (OB) and one of which was high-grade surface osteosarcoma (HGS), possessed IDH2 mutations. The gene discussed is IDH2; the disease is osteosarcoma.